NEFL and amyotrophic lateral sclerosis: For example, Brodovitch et al. showed that coupling CSF NfL with CSF intercellular adhesion molecule-1, a marker of vascular damage, and with serum interferon gamma, a marker of peripheral inflammation, better discriminated patients with ALS from those with inflammatory peripheral neuropathies than when using CSF NfL alone [43].